Opravil, M <br/><br/>
Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Feb 1995 
 - 244-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1058-4838 
<br/><br/><label>Standard No.: </label>10.1093/clinids/20.2.244  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>CD4 Lymphocyte Count<br/>Dapsone--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>HIV Infections--complications<br/>HIV-1--immunology<br/>Humans<br/>Immunocompromised Host<br/>Male<br/>Mycobacterium Infections--prevention & control<br/>Mycobacterium avium-intracellulare Infection--prevention & control<br/>Nebulizers and Vaporizers<br/>Pentamidine--administration & dosage<br/>Pneumonia, Pneumocystis--prevention & control<br/>Prospective Studies<br/>Pyrimethamine--therapeutic use<br/>Retrospective Studies<br/>Toxoplasmosis, Cerebral--prevention & control<br/>Tuberculosis, Pulmonary--prevention & control